Structural guidance of the photocycle of channelrhodopsin-2 by an interhelical hydrogen bond.
Channelrhodopsin-2 (ChR2) is a light-gated cation channel and a member of the family of retinylidene photoreceptors. Since the demonstration of light-induced depolarization of ChR2-expressing animal cell membranes, it was increasingly exploited for light triggering of action potentials. ChR2 conducts cations upon light absorption that embodies retinal isomerization as the primary reaction and a structurally unknown opening mechanism. It is evident from spectroscopic data that protonation reactions at the Schiff base are part of the photocycle, comparable to other microbial-type rhodopsins. However, the connection between the processes at the chromophore site and the channel's pore remained enigmatic. Here, we use slow mutants of ChR2 that we generated by disturbing a postulated hydrogen bond when mutating C128 in the transmembrane (TM) helix 3 and D156 in TM helix 4. The lifetime of the mutants' open state is increased more than 100 times. We investigated the spectral properties of the slow mutants. Whereas the deprotonation of the Schiff base (yielding P390) occurs on the same time scale as that of the wild type, reprotonation to P520 is retarded in the slow mutants and their photocycle is split, leading to the presence of two photointermediates, P390 and P520, in the open state. The photoreactions of P390 and P520 lead to a quenching of the current in electrophysiological measurements. We conclude that the putative hydrogen bond between C128 and D156 is an important structural determinant of the channel's closing reaction. Furthermore, we show that the D156A mutant is even more suitable for light control of excitable cells than C128A.
Bamann
Christian
C
Max-Planck-Institut für Biophysik, Max-von-Laue Strasse 3, 60438 Frankfurt, Germany. Christian.bamann@biophys.mpg.de
Gueta
Ronnie
R
Kleinlogel
Sonja
S
Nagel
Georg
G
Bamberg
Ernst
E
D000818:Animals; D002460:Cell Line; D000075402:Channelrhodopsins; D018076:DNA, Complementary; D005260:Female; D014644:Genetic Variation; D006801:Humans; D016297:Mutagenesis, Site-Directed; D009419:Nerve Tissue Proteins / Q000737:chemistry / Q000235:genetics; D009865:Oocytes / Q000502:physiology; D010782:Photolysis; D010843:Pichia / Q000502:physiology; D017354:Point Mutation; D020641:Polymorphism, Single Nucleotide; D015183:Restriction Mapping; D014162:Transfection; D014981:Xenopus / Q000502:physiology
D000075402:Channelrhodopsins; D018076:DNA, Complementary; D009419:Nerve Tissue Proteins